CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-27 | Grossman Adam S President and CEO | Sale | −389,356 | $17.29 | $6.7M | 2,059,726 |
| 2024-08-27 | Grossman Adam S President and CEO | Option exercise · Common Stock | −341,960 | $3.35 | $1.1M | 741,020 |
| 2024-08-27 | Grossman Adam S President and CEO | Option exercise · Common Stock | −47,396 | $2.92 | $138K | 0 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise | +64,405 | $3.35 | $216K | 2,124,131 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise | +55,000 | $5.00 | $275K | 2,179,131 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise | +16,984 | $5.96 | $101K | 2,196,115 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise | +40,500 | $9.37 | $379K | 2,236,615 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise | +60,000 | $10.80 | $648K | 2,296,615 |
| 2024-08-26 | Grossman Adam S President and CEO | Sale | −236,889 | $17.69 | $4.2M | 2,059,726 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise · Common Stock | −64,405 | $3.35 | $216K | 1,082,980 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise · Common Stock | −55,000 | $5.00 | $275K | 0 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise · Common Stock | −16,984 | $5.96 | $101K | 0 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise · Common Stock | −40,500 | $9.37 | $379K | 0 |
| 2024-08-26 | Grossman Adam S President and CEO | Option exercise · Common Stock | −60,000 | $10.80 | $648K | 0 |
| 2024-08-23 | KWON YOUNG Director | Sale | −60,000 | $18.26 | $1.1M | 241,441 |
| 2024-07-24 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −2,502 | $13.58 | $34K | 449,088 |
| 2024-07-24 | Tade Brad L. CFO and Treasurer | Grant or award | +72,400 | 214,433 | ||
| 2024-07-24 | Tade Brad L. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +115,100 | 115,100 | ||
| 2024-06-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −2,085 | $11.18 | $23K | 451,590 |
| 2024-06-30 | Grossman Adam S President,CEO, and Interim CFO | Shares withheld for taxes | −21,752 | $11.18 | $243K | 2,059,726 |
Page 11 of 31 · 618 trades